APT Medical Inc (688617) - Total Liabilities

Latest as of March 2026: CN¥423.40 Million CNY ≈ $61.96 Million USD

Based on the latest financial reports, APT Medical Inc (688617) has total liabilities worth CN¥423.40 Million CNY (≈ $61.96 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore APT Medical Inc net asset momentum to track the company's year-over-year net asset growth rate.

APT Medical Inc - Total Liabilities Trend (2017–2025)

This chart illustrates how APT Medical Inc's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does APT Medical Inc generate to measure how efficiently the company converts operating cash flow to free cash.

APT Medical Inc Competitors by Total Liabilities

The table below lists competitors of APT Medical Inc ranked by their total liabilities.

Company Country Total Liabilities
WHITE MTNS INS. GRP DL 1
F:WNI
Germany €6.05 Billion
FLSmidth & Co.
CO:FLS
Denmark Dkr12.59 Billion
Brinks Company
NYSE:BCO
USA $6.88 Billion
Minth Group Limited
F:M3I
Germany €17.89 Billion
Hamilton Lane Inc
NASDAQ:HLNE
USA $844.76 Million
Netwealth Group Ltd
AU:NWL
Australia AU$156.90 Million
Asia Commercial Bank
VN:ACB
Vietnam ₫931.33 Trillion
Kumba Iron Ore Ltd
JSE:KIO
South Africa ZAC31.70 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down APT Medical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see APT Medical Inc market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 5.20 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.14 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.12 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how APT Medical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for APT Medical Inc (2017–2025)

The table below shows the annual total liabilities of APT Medical Inc from 2017 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥477.40 Million
≈ $69.86 Million
+12.10%
2024-12-31 CN¥425.85 Million
≈ $62.32 Million
-30.30%
2023-12-31 CN¥610.98 Million
≈ $89.41 Million
+40.48%
2022-12-31 CN¥434.91 Million
≈ $63.64 Million
+95.89%
2021-12-31 CN¥222.02 Million
≈ $32.49 Million
+60.16%
2020-12-31 CN¥138.62 Million
≈ $20.29 Million
-35.56%
2019-12-31 CN¥215.13 Million
≈ $31.48 Million
+290.28%
2018-12-31 CN¥55.12 Million
≈ $8.07 Million
+43.89%
2017-12-31 CN¥38.31 Million
≈ $5.61 Million
--

About APT Medical Inc

SHG:688617 China Medical Devices
Market Cap
$4.33 Billion
CN¥29.58 Billion CNY
Market Cap Rank
#3933 Global
#576 in China
Share Price
CN¥209.71
Change (1 day)
-2.45%
52-Week Range
CN¥181.27 - CN¥331.86
All Time High
CN¥453.00
About

APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagno… Read more